Chief Paul Hudson’s strategy aims to shift focus to therapies for rarer diseases
Home/FT/Sanofi agrees $3.4bn deal for Principia Biopharma FT Sanofi agrees $3.4bn deal for Principia Biopharma Financial Times0 Less than a minute Facebook X LinkedIn Chief Paul Hudson’s strategy aims to shift focus to therapies for rarer diseases Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
